Current approaches to pathogenetic therapy of multiple sclerosis
Saved in:
| Date: | 2015 |
|---|---|
| Main Authors: | Ye. Chernenko, V. I. Vovk |
| Format: | Article |
| Language: | English |
| Published: |
2015
|
| Series: | International medical journal |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000366331 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Multiple sclerosis
by: Palinskyy, I.Z.
Published: (2008)
by: Palinskyy, I.Z.
Published: (2008)
Systemic disorders in patients with multiple sclerosis
by: I. A. Grigorova
Published: (2018)
by: I. A. Grigorova
Published: (2018)
Albumin as a parameter permeability of the blood-brain barrier in multiple sclerosis patients
by: M. E. Chernenko
Published: (2013)
by: M. E. Chernenko
Published: (2013)
Modern view on possibilities and directions of pathogenetic therapy of patients with tuberculosis
by: I. I. Hrek, et al.
Published: (2021)
by: I. I. Hrek, et al.
Published: (2021)
Pain and vertebrogenic syndromes in patients with multiple sclerosis (Review of Literature)
by: T. Nehrych, et al.
Published: (2018)
by: T. Nehrych, et al.
Published: (2018)
Changes of antinociceptive potential combinations of analgesics with methylprednisolone in experimental multiple sclerosis
by: O. O. Nefodov, et al.
Published: (2015)
by: O. O. Nefodov, et al.
Published: (2015)
Clinical activity risk factors and long-term prognosis of relapsing-remitting multiple sclerosis
by: T. A. Kobys, et al.
Published: (2014)
by: T. A. Kobys, et al.
Published: (2014)
Enzyme blood level disorder as a marker of metabolic processes severity in multiple sclerosis
by: E. V. Markovskaja
Published: (2014)
by: E. V. Markovskaja
Published: (2014)
Enzyme blood level disorder as a marker of metabolic processes severity in multiple sclerosis
by: Markovskaya, E.V
Published: (2014)
by: Markovskaya, E.V
Published: (2014)
Freezing influences, the exposure of IgG glycans in sera from multiple sclerosis patients
by: M. Bozhenko, et al.
Published: (2020)
by: M. Bozhenko, et al.
Published: (2020)
Clinical course peculiarities in patients with multiple sclerosis in vinnytsia region on the basis of vitamin D content
by: S. L. Malyk
Published: (2015)
by: S. L. Malyk
Published: (2015)
Autoantibodies to myelin basic protein and histone H1 as immune biomarkers of neuropsychological disorders in patients with multiple sclerosis
by: S. Y. Kyryliuk, et al.
Published: (2020)
by: S. Y. Kyryliuk, et al.
Published: (2020)
Materials of international scientific conference “Integrated clinical and pathogenetic approaches in diagnosis and therapy of cancer”, June 13–15, 2016, Kyiv, Ukraine
Published: (2016)
Published: (2016)
Hypochlorous model of systemic sclerosis induction
by: L. M. Zaiats, et al.
Published: (2020)
by: L. M. Zaiats, et al.
Published: (2020)
Current clinical and pathogenetic aspects of diagnosis and treatment of patients with cervical ectopia
by: N. A. Shcherbina, et al.
Published: (2014)
by: N. A. Shcherbina, et al.
Published: (2014)
Neuroprotective effect of the recombinant human leukemia inhibitory factor in mice with an experimental cuprizone model of multiple sclerosis: possible mechanisms
by: Labunets, I.F., et al.
Published: (2018)
by: Labunets, I.F., et al.
Published: (2018)
Glatiramer Acetate Treatment-Related Effects on Visual EPs and P300 Wave in Patients Suffering from Multiple Sclerosis
by: Major, Z.Z., et al.
Published: (2013)
by: Major, Z.Z., et al.
Published: (2013)
Glatiramer Acetate Treatment-Related Effects on Visual EPs and P300 Wave in Patients Suffering from Multiple Sclerosis
by: Z. Z. Major, et al.
Published: (2013)
by: Z. Z. Major, et al.
Published: (2013)
Study of association between polymorphisms in the PSMB5 (rs11543947) and PSMA3 (rs2348071) genes and multiple sclerosis in Latvians
by: Kalnina, J., et al.
Published: (2014)
by: Kalnina, J., et al.
Published: (2014)
Study of association between polymorphisms in the PSMB5 (rs11543947) and PSMA3 (rs2348071) genes and multiple sclerosis in Latvians
by: J. Kalnina, et al.
Published: (2014)
by: J. Kalnina, et al.
Published: (2014)
Pathogenetic aspects of early cardiometabolic therapy in patients with acute coronary syndrome with no-st segment elevation after percutaneus coronary intervention
by: O. O. Jakimenko, et al.
Published: (2015)
by: O. O. Jakimenko, et al.
Published: (2015)
Problem of neurogenesis in therapy of neuroinflammatory/neurodegenerative process
by: Ye. Chernenko
Published: (2019)
by: Ye. Chernenko
Published: (2019)
Nonalcoholic steatohepatitis and pathogenetic correction methods
by: T. D. Zvjagintseva, et al.
Published: (2014)
by: T. D. Zvjagintseva, et al.
Published: (2014)
Pathogenetic conditioning of peptidases assignments in the treatment of patients with generalized periodontitis
by: Ye. Serheieva
Published: (2013)
by: Ye. Serheieva
Published: (2013)
Pathogenetic substantiation of ways to improve the diagnostics pyelonephritis
by: A. N. Likhoded, et al.
Published: (2014)
by: A. N. Likhoded, et al.
Published: (2014)
Obesity: clinical and pathogenetic justification of prevention and treatment
by: O. M. Korzh
Published: (2020)
by: O. M. Korzh
Published: (2020)
Clinical and pathogenetic parallels with complex hemodilution treatment of COPD
by: O. V. Kucher, et al.
Published: (2013)
by: O. V. Kucher, et al.
Published: (2013)
Clinical and pathogenetic substantiation of the treatment of synthropic gastropathy and COPD
by: A. I. Hozhenko, et al.
Published: (2013)
by: A. I. Hozhenko, et al.
Published: (2013)
New approach to early gestosis therapy
by: I. A. Kudrevich
Published: (2005)
by: I. A. Kudrevich
Published: (2005)
Pathogenetic role of myocardial fibrosis: focus on extracellular matrix
by: T. M. Ambrosova, et al.
Published: (2020)
by: T. M. Ambrosova, et al.
Published: (2020)
Pathogenetic classification of dysregulatory conditions of operators of transport(Report 2)
by: O. V. Gorsha, et al.
Published: (2014)
by: O. V. Gorsha, et al.
Published: (2014)
The activity of erythropoietin as the pathogenetic component of anemia in acute myeloid leukemia
by: I. I. Lanovenko, et al.
Published: (2014)
by: I. I. Lanovenko, et al.
Published: (2014)
Vascular endothelial growth factor in psoriasis: pathogenetic and therapeutic aspects
by: E. I. Sarian
Published: (2013)
by: E. I. Sarian
Published: (2013)
Glycated proteins in diabetes: the phenomenon of formation and pathogenetic effects (review)
by: T. M. Boichuk, et al.
Published: (2013)
by: T. M. Boichuk, et al.
Published: (2013)
Dephosphorylation of tuberous sclerosis complex 2 by serine/threonine protein phosphatase 5
by: Malanchuk, O.M., et al.
Published: (2008)
by: Malanchuk, O.M., et al.
Published: (2008)
Modern approaches to the therapy of pediatric alopecia areata
by: I. M. Serbina
Published: (2018)
by: I. M. Serbina
Published: (2018)
Pathogenetic role of infusion component in traumatic disease in geriatric patients
by: Ju. V. Volkova
Published: (2015)
by: Ju. V. Volkova
Published: (2015)
Ribonucleases. possible new approach in cancer therapy
by: Shlyakhovenko, V.O.
Published: (2016)
by: Shlyakhovenko, V.O.
Published: (2016)
Ribonucleases. Possible new approach in cancer therapy
by: V. O. Shlyakhovenko
Published: (2016)
by: V. O. Shlyakhovenko
Published: (2016)
Molecular modeling in the radiation therapy. The algebraic approach
by: Volkov, V.A., et al.
Published: (2023)
by: Volkov, V.A., et al.
Published: (2023)
Similar Items
-
Multiple sclerosis
by: Palinskyy, I.Z.
Published: (2008) -
Systemic disorders in patients with multiple sclerosis
by: I. A. Grigorova
Published: (2018) -
Albumin as a parameter permeability of the blood-brain barrier in multiple sclerosis patients
by: M. E. Chernenko
Published: (2013) -
Modern view on possibilities and directions of pathogenetic therapy of patients with tuberculosis
by: I. I. Hrek, et al.
Published: (2021) -
Pain and vertebrogenic syndromes in patients with multiple sclerosis (Review of Literature)
by: T. Nehrych, et al.
Published: (2018)